LEXINGTON, Mass., March 22, 2018 /PRNewswire/ -- Aldeyra
Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology
company devoted to development of next-generation medicines to
improve the lives of patients with inflammatory diseases, will
issue financial results for the year ended December 31, 2017, on Thursday, March 29, 2018, prior to the market
open.
Aldeyra will hold a conference call on Thursday, March 29, 2018, at 8:00 a.m. EDT to discuss the results. The
dial-in numbers are 1-877-266-8979 for domestic callers and
1-412-317-5231 for international callers. A live webcast of
the conference call will also be available on the investor
relations page of the Aldeyra Therapeutics corporate website
at www.aldeyra.com.
After the live webcast, the event will remain archived on the
Aldeyra Therapeutics website for one year.
About Aldeyra
Therapeutics
Aldeyra Therapeutics is
developing next-generation medicines to improve the lives of
patients with inflammatory diseases. Aldeyra's lead product
candidate, reproxalap, is a first-in-class treatment in late-stage
development for dry eye disease and other forms of ocular
inflammation. Aldeyra is leveraging its experience in ocular
inflammation to develop other product candidates for systemic
inflammatory disease. None of Aldeyra's product candidates have
been approved for sale in the U.S. or elsewhere.
Corporate Contact:
Stephen Tulipano
Aldeyra Therapeutics, Inc.
Tel: +1 781-761-4904 ext. 205
stulipano@aldeyra.com
Investor Contact:
Chris Brinzey
Westwicke Partners
Tel: 339-970-2843
Chris.brinzey@westwicke.com
Media Contact:
Cammy Duong
MacDougall Biomedical Communications
781-591-3443
cduong@macbiocom.com
View original
content:http://www.prnewswire.com/news-releases/aldeyra-therapeutics-schedules-webcast-and-conference-call-to-provide-full-year-2017-financial-results-300618473.html
SOURCE Aldeyra Therapeutics, Inc.